5
56
Growth Score 5 in past quarter
-4 pts
Heat Score 56 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
224543
Telehealth platform for allergy immunotherapy, sublingual allergy drops, allergy testing & convenient alternative to allergy shots
- Alexios Shaw: COO
- Gene Kakaulin: Co-Founder & CEOPast Role: Hiline Coffee, Co-Founder & CEO
About the Company
Curex offers the most accessible and convenient form of allergy immunotherapy in the U.S. Our at-home offering starts at just $59/month and results in better outcomes and 3x higher adherence than traditional allergy shots.
With over 50,000 users across the U.S., Curex is trusted by hundreds of doctors and is in-network with over 80% of health
plans.